Correlation Between Viridian Therapeutics and Repligen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Repligen, you can compare the effects of market volatilities on Viridian Therapeutics and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Repligen.

Diversification Opportunities for Viridian Therapeutics and Repligen

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viridian and Repligen is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Repligen go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Repligen

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 5.83 times less return on investment than Repligen. In addition to that, Viridian Therapeutics is 1.64 times more volatile than Repligen. It trades about 0.04 of its total potential returns per unit of risk. Repligen is currently generating about 0.39 per unit of volatility. If you would invest  14,305  in Repligen on November 2, 2024 and sell it today you would earn a total of  2,448  from holding Repligen or generate 17.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Repligen

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Repligen 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Repligen are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile technical and fundamental indicators, Repligen displayed solid returns over the last few months and may actually be approaching a breakup point.

Viridian Therapeutics and Repligen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Repligen

The main advantage of trading using opposite Viridian Therapeutics and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.
The idea behind Viridian Therapeutics and Repligen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets